Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
Published:
Last Updated:
The short interest data are out for the May 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Amgen Inc. (NASDAQ: AMGN) saw its short interest rise to 7.50 million shares from the previous level of 7.36 million. Shares closed most recently at $152.72, in a 52-week trading range of $130.09 to $181.81.
Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.24 million shares from the previous level of 1.95 million. The stock closed Tuesday at $272.94, within a 52-week range of $242.07 to $420.99.
Celgene Corp. (NASDAQ: CELG) short interest for this settlement date increased to 8.94 million shares from the previous 7.97 million. Shares closed most recently at $103.70, in a 52-week range of $92.98 to $140.72.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest decrease to 23.36 million shares from 28.07 million in the previous period. Shares closed Tuesday at $86.22, in a 52-week trading range of $81.28 to $123.37.
MannKind Corp. (NASDAQ: MNKD) saw its short interest decrease to 97.22 million shares. The previous reading was 105.71 million. Shares closed most recently at $0.97, in a 52-week trading range of $0.64 to $7.32.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest decreased to 5.49 million, compared to the previous level of 5.56 million. Shares closed most recently at $146.67, in a 52-week range of $124.16 to $208.88.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
